Abstract
We encountered a case of acute myeloblastic leukemia (AML), with extramedullary leukemia (EML) and a masked type of the variant translocation t(8;21)(q22;q22). Morphologically, the AML M2 subtype according to the French–American–British (FAB) classification was present. Phenotypically, leukemic cells were negative for CD19 and positive for CD56. Clinically, the case showed chemo-refractoriness and a poor outcome. The initial karyotypic interpretation was t(8;9)(q22;q34) on G-banding. Multiplex-fluorescence in situ hybridization (multiplex-FISH) analysis revealed a three-way translocation involving chromosomes 8, 9, and 21, and identified a masked type of variant t(8;21)q22;q22) translocation. The karyotype was finally determined as 45,X,-Y,der(8)t(8;21)(q22;q22), der(9)(8;9)(q22;q34), and der(21)t(9;21)(q34;q22). Results of FISH using the AML1/ETO probe and detection of the AML1/ETO fusion transcripts by reverse transcriptase-polymerase chain reaction (RT-PCR) support the karyotype as well as the sequence of the PCR product. Additionally, C-KIT mutation was detected.
References
Rowly JD. Recurring chromosomal abnormalities in leukemia and lymphoma. Semin Hematol. 1997;27:122–36.
Miyoshi H, Kozu T, Shimizu K, et al. The t(8;21) tranlocation in acute myeloid leukemia results in production of an AML1-MTG8 fusion transcript. EMBO J. 1993;12:2715–21.
Bennett JM, Catovsky D, Daniel MT, et al. Proposed revised criteria for the classification of acute myeloid leukemia: a report of the French–American–British Cooperative Group. Ann Intern Med. 1985;103:620–5.
TrujilloJM, Cork A, Aheam MJ, et al. Hematologic and cytologic characterization of 8/21 translocation acute granulocytic leukemia. Blood. 1979;53:695–706.
Bloomfield CD, Lawrence D, Byrd JC, et al. Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype. Cancer Res. 1998;58:4173–9.
Rege K, Swanbury GJ, Arta AA, et al. Disease features in acute myeloid leukemia with t(8;21)(q22;q22). Influence of age, secondary karyotype abnormalities, CD19 status, and extramedullary leukemia on survival. Leuk Lymphoma. 2000;40:67–77.
Xue Y, Nju C, Chen S, et al. Two cases of AML(M2) with a t(8;21)(q22;q13): a new cytogenetic variant. Cancer Genet Cytogenet. 2000;118:154–8.
Viera L, Oliveira V, Ambrosio AP, et al. Translocation (8;17;15;21)(q22;q23;q15;q22) in acute myeloid leukemia(M2): a four-way variant of t(8;21). Cancer Genet Cytogenet. 2001;128:104–7.
Gallego M, Carroll AJ, Gad GS, et al. Variant t(8;21) rearrangements in acute myeloblastic leukemia of childhood. Cancer Genet Cytogenet. 1994;75:139–44.
Osumi K, Fukui T, Kiyoi H, et al. Rapid screening of leukemia fusion transcripts in acute leukemia by real-time PCR. Leuk Lymphoma. 2002;43:2291–9.
Speicher MR, Ballard SG, Ward DC. Karyotyping human chromosomes by combinatorial multi-fluor FISH. Nat Genet. 1996;12:368–75.
Monma F, Nishii K, Yamamori S, et al. Fluorescent in situ hybridization analysis of Philadelphia chromosome-negative chronic myeloid leukemia with the bcr/abl fusion gene. Int J Hematol. 2004;80:155–8.
Foster R, Griffith R, Ferrao P, Ashman L. Molecular basis of the constitutive activity and STI571 resistance of Asp816Val mutant KIT receptor tryrosine kinase. J Mol Graph Model. 2004;23:139–52.
Kita K, Nakase K, Miwa H, et al. Phenotypical characteristics of acute myeloid leukemia associated with the t(8;21)(q22;q22) chromosomal abnormalitiy: frequent expression of immature B-cell antigen CD19 together with stem cell antigen CD34. Blood. 1992;80:470–7.
Baer MR, Stewart CC, Lawrence D, et al. Expression of the neural cell adhesion molecule CD56 is associated with short remission duration and survival in acute myeloid leukemia with t(8;21)(q22;q22). Blood. 1997;90:1643–8.
Nishi K, Usui E, Katayama N , et al. Characteristics of t(8;21) acute myeloid leukemia (AML) with additional chromosomal abnormality: concomitant trisomy 4 may constitute a distinctive subtype of t(8;21) AML. Leukemia. 2003;17:731–7.
Miyamoto T, Weissman IL, Akashi K. AML1/ETO-expressing nonleukemic stem cells in acute myelogenous leukemia with 8;21 chromosomal translocation. Proc Natl Acad Sci USA. 2000;97:7521–6.
Cairoli R, Beghini A, Grillo G, et al. Prognostic impact of c-KIT mutations in core binding factor leukemias: an Italian retrospective study. Blood. 2006;107:3463–8.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Kawakami, K., Nishii, K., Hyou, R. et al. A case of acute myeloblastic leukemia with a novel variant of t(8;21)(q22;q22). Int J Hematol 87, 78–82 (2008). https://doi.org/10.1007/s12185-007-0010-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12185-007-0010-2